AU2002213996A1 - Method for producing phyllanthus extracts - Google Patents

Method for producing phyllanthus extracts

Info

Publication number
AU2002213996A1
AU2002213996A1 AU2002213996A AU1399602A AU2002213996A1 AU 2002213996 A1 AU2002213996 A1 AU 2002213996A1 AU 2002213996 A AU2002213996 A AU 2002213996A AU 1399602 A AU1399602 A AU 1399602A AU 2002213996 A1 AU2002213996 A1 AU 2002213996A1
Authority
AU
Australia
Prior art keywords
phyllanthus
preferred
extract
concentrated
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213996A
Other languages
English (en)
Inventor
Matthias-Heinrich Kreuter
Gerolf Tittel
Hildebert K. M. Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CMI-CENTERS FOR MEDICAL INNOVATION AG
Original Assignee
CMI AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CMI AG filed Critical CMI AG
Publication of AU2002213996A1 publication Critical patent/AU2002213996A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
AU2002213996A 2000-10-06 2001-10-05 Method for producing phyllanthus extracts Abandoned AU2002213996A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00121852 2000-10-06
EP00121852 2000-10-06
EP01100825 2001-01-15
EP00100825 2001-01-15
PCT/EP2001/011526 WO2002030436A1 (fr) 2000-10-06 2001-10-05 Procede de production d'extraits de phyllanthus

Publications (1)

Publication Number Publication Date
AU2002213996A1 true AU2002213996A1 (en) 2002-04-22

Family

ID=26071483

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213996A Abandoned AU2002213996A1 (en) 2000-10-06 2001-10-05 Method for producing phyllanthus extracts

Country Status (10)

Country Link
US (1) US7074436B2 (fr)
EP (1) EP1326624B1 (fr)
JP (1) JP2004510822A (fr)
AT (1) ATE275413T1 (fr)
AU (1) AU2002213996A1 (fr)
CA (1) CA2424930A1 (fr)
DE (1) DE50103561D1 (fr)
ES (1) ES2227298T3 (fr)
PT (1) PT1326624E (fr)
WO (1) WO2002030436A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1278629C (zh) * 2001-06-21 2006-10-11 协和发酵工业株式会社 含有植物体粉末的植物提取物的制造方法
ES2300783T3 (es) * 2003-07-01 2008-06-16 Max Zeller Sohne Ag Procedimiento de extraccion vegetal y extracto.
EP2116253A1 (fr) 2008-05-07 2009-11-11 Phytrix JV, LLC Nouvel extrait de Phyllanthus
EP3954379A1 (fr) 2020-08-12 2022-02-16 HFM - Hybrid Fusion Medicals, GmbH Compositions comprenant de l'extrait de phyllanthus destinées à être utilisées dans le traitement ou la prévention d'une infection sars-cov-2 et/ou au moins un symptôme de covid-19

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US161477A (en) * 1875-03-30 Improvement in curtain-fixtures
US28754A (en) * 1860-06-19 Congress boot
FR1206300A (fr) * 1957-08-16 1960-02-09 Réacteur nucléaire à combustible sous forme sphéroïde
US3272796A (en) * 1957-08-16 1966-09-13 Oletta Sa Salt of alkaloid from phyllanthus discodeus
DE3131471A1 (de) 1981-03-20 1982-09-30 Roderich Wilhelm Dr.-Ing. 6100 Darmstadt Gräff Vorrichtung zum trocknen feuchter abluft aus einem oder mehreren schuettgut-trocknungsbehaeltern
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
US4673575A (en) * 1985-04-26 1987-06-16 Fox Chase Cancer Center Composition, pharmaceutical preparation and method for treating viral hepatitus
US4937074A (en) 1988-03-29 1990-06-26 Fox Chase Cancer Center Method of treating retrovirus infection
WO1990004968A1 (fr) 1988-10-31 1990-05-17 University Of North Carolina At Chapel Hill Inhibition de retrovirus humains
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
US5648089A (en) * 1995-07-03 1997-07-15 Shawkat; Tarek Extract solution and herbal mixture for treatment of hepatitis
US6136316A (en) * 1996-04-17 2000-10-24 Dabur Research Foundation Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
WO2000056347A1 (fr) * 1999-03-24 2000-09-28 Southern Petrochemical Industries Corporation Limited Fraction enrichie preparee a partir de phyllanthus amarus pour le traitement de l'hepatite et preparation de cette fraction
DE19919585A1 (de) * 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
DE10030139A1 (de) 2000-06-20 2002-01-10 Cmi Ag Verwendung von Phyllanthusbesandteilen zur Behandlung oder Prophylaxe von Infekten durch Flaviviridae
JP2004513092A (ja) 2000-10-06 2004-04-30 シーエムアイ−センターズ・フォー・メディカル・イノヴェーション・アクチェンゲゼルシャフト ヌクレオシド性阻害剤耐性レトロウイルス又は非ヌクレオシド性阻害剤耐性レトロウイルスに付随した疾患の予防及び／又は治療のためのＰｈｙｌｌａｎｔｈｕｓ由来の化合物

Also Published As

Publication number Publication date
US20040033275A1 (en) 2004-02-19
ATE275413T1 (de) 2004-09-15
EP1326624B1 (fr) 2004-09-08
CA2424930A1 (fr) 2003-04-04
DE50103561D1 (de) 2004-10-14
US7074436B2 (en) 2006-07-11
JP2004510822A (ja) 2004-04-08
PT1326624E (pt) 2005-01-31
WO2002030436A1 (fr) 2002-04-18
EP1326624A1 (fr) 2003-07-16
ES2227298T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
HK1061203A1 (en) A process for the manufacture of a herbal composition comprising a matrine
KR100318019B1 (ko) 항암활성을가지는황칠나무추출물
HUP0401344A2 (hu) Gyógyszerkészítmények opioidokkal való visszaélés megakadályozására, és eljárás előállításukra
HUP0300826A2 (hu) Egy epotilon-analóg polimorfjai, eljárás az elżállításukra és ezeket tartalmazó gyógyszerkészítmények
WO2003045411A3 (fr) Preparation a base d'extrait de gingembre
KR20050025588A (ko) 올리브 식물수로부터의 히드록시티로졸-풍부 조성물 및그의 사용 방법
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
CA2589994A1 (fr) Composition pharmaceutique pour le traitement et/ou la prevention de l'hyperlipidemie, procedes de production et utilisation de cette composition
LT2004101A (en) Pharmaceutical composition
MY128368A (en) Method for producing quickly decomposable solid pharmaceutical preparations
HK1069995A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
CA2356896A1 (fr) Methode d'extraction a haut rendement de paclitaxel a partir de matiere contenant du paclitaxel
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
Li et al. The bioavailability of ginkgolides in Ginkgo biloba extracts
AU3677589A (en) Pharmaceutical product having epidermial regenerative activity based on the active ingredient of mimosa tenuiflora and process for its obtention
MY137846A (en) Processes for the preparation of oral dosage formulations of modafinil
AU2002213996A1 (en) Method for producing phyllanthus extracts
WO2004033448A3 (fr) Isolation, purification et synthese de procyanidine b2, et ses utilisations
RU2000120474A (ru) Фармацевтическая композиция, обладающая противоопухолевой активностью и способ ее получения
AU7795800A (en) Method for supercritical fluid extraction
JPH11279039A (ja) 口腔用組成物
YU67492A (sr) Postupak za dobijanje farmaceutskog sredstva
JP2006257060A (ja) テストステロン５α−レダクターゼ阻害剤及びそれを配合した頭髪用剤及び皮膚外用剤。
Kulevanova et al. HPLC identification and determination of flavone aglycones in Helichrysum plicatum DC.(Asteraceae)
WO2006012779A8 (fr) Extraits de wikstroemia indeca, production de ceux-ci et utilisation de ceux-ci dans la production de produits pharmaceutiques anti-inflammatoires